ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Obama Calls for Bigger Investment in Science, GOP Plans Cuts

January 28, 2011

Bass & Howes Bought By DDB Seattle

March 22, 2002

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends

April 30, 1999